Corxel

Series-B
corxelbio.com Biotech & Healthcare 51–100 employees
Total Funding $287M
Latest Round $287M Series-B
Last Announced Jan 26, 2026
Investors 10 Backers
Decision Makers Profile Active

About Corxel

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Team Size 51–100 employees
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website corxelbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $287,000,000 · Series-B

    news.google.com

Investors & Backers

10
Adage Capital Management
HBM Healthcare Investments
Hengdian Group
Invus
RA Capital Management
RTW Investments
SilverArc Capital
SR One
SymBiosis
TCG Crossover

Funding History

1 Round
Series-B equity · Jan 26, 2026
$287,000,000 news.google.com

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts